Instem plc, a leading provider of IT solutions and services to the global life sciences market, has acquired its Swiss competitor PDS Pathology Data Systems AG, with offices in the United States and Japan, at an enterprise value of CHF 14.25m.
The VISCHER Dispute Resolution team led by Thomas Weibel successfully defended a Swiss bank in a multi-front battle.
The VISCHER dispute resolution team successfully enforced an ICC arbitral award rendered in London and stemming from international commodity trading in Switzerland.
The shareholders of the evitria Group have sold the evitria Group to Atlas Antibodies, Sweden. The transaction was completed on August 5, 2021.
Rigeto portfolio company Swissphone acquires instaSOLUTION AG. The transaction was completed on July 16, 2021.
RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company, has entered into a binding agreement with two U.S. institutional investors to purchase in a private placement Relief shares of CHF 15m total.
RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company, has issued 1,000,000,000 additional registered shares out of the authorized share capital approved by the Annual General Meeting on 18 June 2021.
International hotel group MEININGER manages its successful market entry in Switzerland and opens new hotels in Zurich and Geneva.
Kuros to receive USD 7m up front and retain the potential to receive up to USD 166.5m in future revenues under a royalty purchase agreement with XOMA Corporation
TargImmune Therapeutics has closed its 2021 financing round, raising CHF 17.7m.